R&G PHARMASTUDIES revenue for the last year amounted to 721.00 M CNY, the most of which — 354.49 M CNY — came from its highest performing source at the moment, Clinical Trial Operation, the year earlier bringing 299.61 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought R&G PHARMASTUDIES 674.39 M CNY, and the year before that — 605.02 M CNY.